Partners4Access (P4A) the specialists in orphan drug access, are presenting 3 posters at the International Society for Pharmacoeconomics and Outcomes Research’s (ISPOR) 20th European Congress in Glasgow from 4th to 8th November 2017.
Select members of the Partners4Access specialist team will be presenting the posters in person:
- Evaluation Framework for digital medicines in Europe (A Krishnan)
- Gene Therapy, the way forward in Europe – The Payer Perspective (C Poschen)
- Role of patient groups in rare disease NICE appraisals – A comparative analysis (N Murad)
Partners4Access specialist team members will be available throughout the conference to discuss your access needs. Contact us to arrange a meeting so we can understand your needs and discuss how to best support you.
Sophie Schmitz, Managing Partner at Partners4Access commented “I’m delighted some of our specialist team will be present at ISPOR to share knowledge and insights into some of the most dynamic areas of healthcare today. Digital health and gene therapy are evolving at a rapid rate and we are heavily involved in shaping the future environment.”
ABOUT P4A
Partners4Access are global consultants specialised in orphan drug access.
The company support the biotechnology and pharmaceutical industry along their launch journey to help secure successful price, reimbursement and access for orphan drugs. Partners4Access has solid partnerships with clients supporting their strategy and operations to effectively ensure launch success.
For more information e-mail [email protected], see our website www.partners4access.com or call us on +44(0)20 38743300
